Penpulimab (AK105)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Penpulimab (AK105), covering 2025-04-13 to 2025-04-13. Get the full timeline:
Most recent: Clinical Trial Update: A Study of Penpulimab (AK105) in the First-line Treatment of Recurrent or Metastatic Nasopharyngeal Carcinoma [Phase 3]